Citadel Advisors’s Quince Therapeutics QNCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $155K | Buy |
93,905
+53,508
| +132% | +$88.3K | ﹤0.01% | 5104 |
|
|
2025
Q1 | $53.7K | Buy |
+40,397
| New | +$53.7K | ﹤0.01% | 5336 |
|
|
2024
Q4 | – | Sell |
-107,007
| Closed | -$83.1K | – | 6622 |
|
|
2024
Q3 | $83.1K | Buy |
107,007
+7,163
| +7% | +$5.56K | ﹤0.01% | 4991 |
|
|
2024
Q2 | $74.9K | Buy |
99,844
+73,388
| +277% | +$55K | ﹤0.01% | 5052 |
|
|
2024
Q1 | $28K | Buy |
+26,456
| New | +$28K | ﹤0.01% | 5477 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 6383 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 6357 |
|
|
2023
Q1 | – | Sell |
-5,288
| Closed | -$3.37K | – | 6436 |
|
|
2022
Q4 | $3.37K | Buy |
+5,288
| New | +$3.37K | ﹤0.01% | 5835 |
|
|
2022
Q3 | – | Sell |
-130,251
| Closed | -$289K | – | 6550 |
|
|
2022
Q2 | $289K | Buy |
+130,251
| New | +$289K | ﹤0.01% | 4671 |
|
|
2022
Q1 | – | Sell |
-62,829
| Closed | -$793K | – | 6964 |
|
|
2021
Q4 | $793K | Sell |
62,829
-31,353
| -33% | -$396K | ﹤0.01% | 4094 |
|
|
2021
Q3 | $8.63M | Buy |
+94,182
| New | +$8.63M | ﹤0.01% | 1575 |
|
|
2021
Q2 | – | Sell |
-32,717
| Closed | -$1.18M | – | 6953 |
|
|
2021
Q1 | $1.18M | Sell |
32,717
-48,683
| -60% | -$1.75M | ﹤0.01% | 3743 |
|
|
2020
Q4 | $2.26M | Sell |
81,400
-222,028
| -73% | -$6.17M | ﹤0.01% | 2446 |
|
|
2020
Q3 | $15.2M | Sell |
303,428
-42,130
| -12% | -$2.11M | ﹤0.01% | 877 |
|
|
2020
Q2 | $16M | Buy |
345,558
+92,344
| +36% | +$4.28M | 0.01% | 843 |
|
|
2020
Q1 | $11.5M | Buy |
253,214
+246,796
| +3,845% | +$11.3M | 0.01% | 906 |
|
|
2019
Q4 | $360K | Sell |
6,418
-5,212
| -45% | -$292K | ﹤0.01% | 3748 |
|
|
2019
Q3 | $290K | Buy |
+11,630
| New | +$290K | ﹤0.01% | 3865 |
|